Grapefruit is a citrus fruit types that can cause adverse reactions when combined with certain medications. But not with the new hybrid grapefruit, which is claimed not to cause negative interactions with medications.
Grapefruit new hybrid developed in Florida have a low furanocoumarin content. Furanocoumarin is a natural chemical compound is the cause of the occurrence of drug interactions.
So far, there are more than 85 known drugs can interact with grapefruit, and 43 of them can cause serious side effects. When combined with certain medications, the furanocoumarin can cause kidney failure and lung, intestinal bleeding, and even sudden death.
Researchers from the University of Florida oranges Fred Gmitter said that the new hybrid grapefruit is now called UF914, has furanocoumarin levels lower than the levels in the regular grapefruit.
Tests were performed on grapefruit UF914 on cultured human cells showed no harmful side effects. Even so, it is necessary to direct human testing.
University of Florida is promoting UF914 which is a cross between a red grapefruit with orange pomelo. May require five to seven years until the product is manufactured on a large scale.
According to Gmitter, research so far aim to create a hybrid grapefruit is sweeter with less bitter taste, but it also had higher levels of furanocoumarin UF914 lower. This product, no seeds, larger, sweeter and less bitter than regular grapefruit.
Furanocoumarin inhibits the enzyme that breaks down some specific drugs, the drugs enter the bloodstream causing a more intense concentration, causing the drug overdose.
Grapefruit new hybrid developed in Florida have a low furanocoumarin content. Furanocoumarin is a natural chemical compound is the cause of the occurrence of drug interactions.
So far, there are more than 85 known drugs can interact with grapefruit, and 43 of them can cause serious side effects. When combined with certain medications, the furanocoumarin can cause kidney failure and lung, intestinal bleeding, and even sudden death.
Researchers from the University of Florida oranges Fred Gmitter said that the new hybrid grapefruit is now called UF914, has furanocoumarin levels lower than the levels in the regular grapefruit.
Tests were performed on grapefruit UF914 on cultured human cells showed no harmful side effects. Even so, it is necessary to direct human testing.
University of Florida is promoting UF914 which is a cross between a red grapefruit with orange pomelo. May require five to seven years until the product is manufactured on a large scale.
According to Gmitter, research so far aim to create a hybrid grapefruit is sweeter with less bitter taste, but it also had higher levels of furanocoumarin UF914 lower. This product, no seeds, larger, sweeter and less bitter than regular grapefruit.
Furanocoumarin inhibits the enzyme that breaks down some specific drugs, the drugs enter the bloodstream causing a more intense concentration, causing the drug overdose.
0 komentar:
Posting Komentar